Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$4.91B+33.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$1.61B+41.8%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$393.48M

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.45B+109%
Enterprise value$1.4B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's total assets?
MapLight Therapeutics, Inc. (MPLT) reported total assets of $418.79M in Q1 2026.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.